Coronavirus: NAFDAC Approves Mass Production Of Chloroquine

Despite that disapproval of Chloroquine as the cure of COVID-19, by the Minister of health, Osagie Ehanire, Nigeria’s drug monitoring agency, NAFDAC, has yesterday announced that it has approved the production of Chloroquine for clinical trials in tackling COVID-19.

In a post by Channels TV, the Director-General of the agency, Mojisola Adeyeye, on Friday in Lagos, said NAFDAC is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.

“In the case of Chloroquine, it has been demonstrated in the literature and with clinical research which is still ongoing, that Chloroquine is superior to the placebo.

“NAFDAC is not approving Chloroquine as a product that can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.

“Therefore the medicine is being approved just for the clinical trials,” Mr Adeyeye said.